Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00072592
What this trial is testing

An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies

Who this might be right for
Wegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableUnknownNCT03979911
What this trial is testing

Evaluation of Pertuzumab-Trastuzumab and Taxane in the Standard Treatment of Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsHER-2 Gene Amplification
University Hospital, Brest 63
Post-approval studies (Phase 4)Study completedNCT00428311
What this trial is testing

Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS

Who this might be right for
Polycystic Ovary Syndrome
Hospital Universitario Ramon y Cajal 50
Not applicableStudy completedNCT01814371
What this trial is testing

Individualized vs. Household MRSA Decolonization

Who this might be right for
Staphylococcal Skin InfectionAbscessFurunculosis+2 more
Washington University School of Medicine 474
Not applicableStudy completedNCT00383500
What this trial is testing

Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status

Who this might be right for
LymphedemaBreast Cancer
Stanford University 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06487000
What this trial is testing

Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Enzychem Lifesciences Corporation 150
Testing effectiveness (Phase 2)UnknownNCT03023592
What this trial is testing

Study of Iguratimod in Sjögren's Syndrome

Who this might be right for
Sjogren's Syndrome
Peking Union Medical College Hospital 30
Not applicableStudy completedNCT06919107
What this trial is testing

Advanced Footwear Technology in Federated Athletes

Who this might be right for
Athlete Foot
University of Oviedo 134
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000292
What this trial is testing

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

Who this might be right for
Lupus Nephritis (LN)ANCA-Associated Glomerulonephritis
Shanghai Changzheng Hospital 12
Testing effectiveness (Phase 2)Study completedNCT02301611
What this trial is testing

Phase IIB TL + YCWP + DC in Melanoma

Who this might be right for
Melanoma
Elios Therapeutics, LLC 187
Post-approval studies (Phase 4)Study completedNCT05134571
What this trial is testing

China Post-marketing Surveillance (PMS) Study of Aldurazyme®

Who this might be right for
Mucopolysaccharidosis I
Genzyme, a Sanofi Company 12
Large-scale testing (Phase 3)Study completedNCT00002707
What this trial is testing

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

Who this might be right for
Breast Cancer
NSABP Foundation Inc 2,411
Early research (Phase 1)Study completedNCT02379507
What this trial is testing

DEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot Study

Who this might be right for
Eczema
Medicus Research, LLC 20
Testing effectiveness (Phase 2)Study completedNCT01164007
What this trial is testing

Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 40
Not applicableUnknownNCT03628092
What this trial is testing

Laser Therapy for Vulvovaginal Symptoms in Breast Cancer Patients

Who this might be right for
Vulvovaginal AtrophyGenitourinary Symptoms and Ill-Defined Conditions
Royal North Shore Hospital 70
Large-scale testing (Phase 3)UnknownNCT02690636
What this trial is testing

Conventional Versus Hypofractionated Radiotherapy in Node Positive Breast Cancer

Who this might be right for
Breast Cancer
Ain Shams University 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT05050136
What this trial is testing

Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis

Who this might be right for
Primary Biliary CholangitisPBC
Mirum Pharmaceuticals, Inc. 333
Testing effectiveness (Phase 2)Study completedNCT01031836
What this trial is testing

Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 30
Early research (Phase 1)Active Not RecruitingNCT04511871
What this trial is testing

A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors

Who this might be right for
Solid TumorGastric CancerBreast Cancer+2 more
Shanghai PerHum Therapeutics Co., Ltd. 12
Large-scale testing (Phase 3)Study completedNCT00765700
What this trial is testing

Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury

Who this might be right for
SprainStrainAcute Soft Tissue Injury
Imprimis Pharmaceuticals, Inc. 364
Next Page